# AnticoagEvaluator vs IVUSAID

The clearest difference is rating: IVUSAID at 5.0 against AnticoagEvaluator's 2.3. AnticoagEvaluator's advantage is ads (none vs listed) and update cadence (every 7 months vs every 18 months). On price, in-app purchases and device support there is nothing between them.

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

IVUSAID holds the better App Store score, 5.0 against 2.3. Both are backed by a comparable volume of ratings — 3 and 1 respectively.

AnticoagEvaluator ships an update every 7 months, IVUSAID every 18 months. The most recent releases landed on November 20, 2026 and November 14, 2026 respectively.

## The numbers

| Metric | AnticoagEvaluator | IVUSAID |
| --- | --- | --- |
| Price | Free | Free |
| Rating | [2.3 (3 ratings)](https://appshunter.io/ios/app/anticoagevaluator/id609795286/reviews) | **[5.0 (1 ratings)](https://appshunter.io/ios/app/ivusaid/id6447531663/reviews)** |
| Number of ratings | **3** | 1 |
| Positive reviews | 30.0% of reviews | — |
| In-app purchases | No | No |
| Ad data | **No** | Yes |
| Update frequency | **Every 7 months** | Every 18 months |
| Monetization | **Free** | Ad-supported |
| Size | 25 MB | 80 MB |
| Requires iOS | **11.0** | 15.0 |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Age rating | 17+ | 17+ |
| Developer | [American College of Cardiology](https://appshunter.io/developer/502174543) | [Cardiology Apps LLC](https://appshunter.io/developer/1639925847) |

## What reviewers say

### AnticoagEvaluator

[App page](https://appshunter.io/ios/app/anticoagevaluator/id609795286)

This medical app assists healthcare professionals in making informed decisions regarding antithrombotic therapy for patients with non-valvular atrial fibrillation. It calculates patient risk factors, provides guideline-driven therapy recommendations, and helps optimize anticoagulant dosages.

**Highlights:** Calculate renal function and stroke/bleed risk, Review ACC/AHA/HRS guideline therapy, Generate individualized antithrombotic risk, Optimize DOAC dosages, Based on SPARC Tool

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases:** none


### IVUSAID

[App page](https://appshunter.io/ios/app/ivusaid/id6447531663)

This free educational app teaches medical professionals how to use intravascular ultrasound (IVUS) for PCI guidance. It features interactive lessons, image interpretation tools, and complex case studies to overcome barriers to IVUS adoption.

**Highlights:** IVUS principles and image acquisition, Image interpretation with videos and descriptions, Complex coronary case studies, Interactive quiz section with explanations, PCI guidance for stent sizing and optimization

**Features:** macOS Compatibility

**In-app purchases:** none


## Frequently asked questions

### Is AnticoagEvaluator free?

AnticoagEvaluator is free to download, with no in-app purchases.

### Is IVUSAID free?

IVUSAID is free to download, with no in-app purchases.

### Which has better reviews, AnticoagEvaluator or IVUSAID?

IVUSAID is rated higher. AnticoagEvaluator averages 2.3 out of 5 from 3 ratings, while IVUSAID averages 5.0 from 1 ratings.

### Do AnticoagEvaluator or IVUSAID have ads?

The App Store privacy details of IVUSAID list data used for advertising; those of AnticoagEvaluator do not.

### Which is updated more often, AnticoagEvaluator or IVUSAID?

AnticoagEvaluator ships an update every 7 months, and IVUSAID every 18 months. Most recently, AnticoagEvaluator was updated on November 20, 2026 and IVUSAID on November 14, 2026.

---

*Compared by [AppsHunter](https://appshunter.io/) from daily US App Store data. Review summaries are generated from verbatim App Store reviews.*
